Jun 18 2011
The Economist examines how "the past decade has seen changes in how vaccines are developed, financed and delivered - solving, at least partially, the conundrum of the vaccine market: poor regions have ample demand for vaccines but little ability to pay for them. As a result, immunisation rates in the poor world have soared." The article looks at how increased competition among manufacturers, especially those in the developing world, and a variety of purchasing schemes are helping to feed a "surge in innovation in the financing and development of vaccines" (6/16).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente. |